21.68
price down icon1.54%   -0.34
after-market アフターアワーズ: 21.68
loading
前日終値:
$22.02
開ける:
$21.99
24時間の取引高:
116.39K
Relative Volume:
0.76
時価総額:
$281.19M
収益:
$56.54M
当期純損益:
$-30.70M
株価収益率:
-55.59
EPS:
-0.39
ネットキャッシュフロー:
$-31.05M
1週間 パフォーマンス:
-10.71%
1か月 パフォーマンス:
+2.65%
6か月 パフォーマンス:
+7.27%
1年 パフォーマンス:
+74.56%
1日の値動き範囲:
Value
$21.57
$22.34
1週間の範囲:
Value
$21.57
$24.91
52週間の値動き範囲:
Value
$10.14
$28.42

Cidara Therapeutics Inc Stock (CDTX) Company Profile

Name
名前
Cidara Therapeutics Inc
Name
セクター
Healthcare (1170)
Name
電話
858-752-6170
Name
住所
6310 NANCY RIDGE DRIVE, SAN DIEGO, CA
Name
職員
73
Name
Twitter
@CidaraThera
Name
次回の収益日
2024-10-31
Name
最新のSEC提出書
Name
CDTX's Discussions on Twitter

CDTX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
CDTX
Cidara Therapeutics Inc
21.68 314.91M 56.54M -30.70M -31.05M -0.39
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Cidara Therapeutics Inc Stock (CDTX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-03-12 開始されました Citizens JMP Mkt Outperform
2025-01-27 再開されました Cantor Fitzgerald Overweight
2024-12-13 開始されました RBC Capital Mkts Outperform
2024-11-08 開始されました Guggenheim Buy
2024-08-14 アップグレード H.C. Wainwright Neutral → Buy
2021-12-03 再開されました H.C. Wainwright Buy
2021-09-22 アップグレード WBB Securities Buy → Strong Buy
2021-03-04 開始されました Aegis Capital Buy
2019-09-04 アップグレード Wedbush Neutral → Outperform
2018-07-26 開始されました Citigroup Buy
2017-04-21 開始されました Raymond James Strong Buy
2017-04-17 繰り返されました H.C. Wainwright Buy
2017-04-12 開始されました Ladenburg Thalmann Buy
2017-04-11 再開されました Wedbush Outperform
2017-02-22 繰り返されました H.C. Wainwright Buy
2017-02-22 アップグレード WBB Securities Sell → Hold
2016-12-21 再開されました Leerink Partners Outperform
2016-12-19 開始されました H.C. Wainwright Buy
2016-09-23 ダウングレード WBB Securities Hold → Sell
2015-10-09 アップグレード WBB Securities Sell → Hold
2015-05-11 開始されました Jefferies Buy
2015-05-11 開始されました Leerink Partners Outperform
2015-05-11 開始されました Needham Buy
2015-05-11 開始されました Wedbush Outperform
2015-04-23 開始されました WBB Securities Sell
すべてを表示

Cidara Therapeutics Inc (CDTX) 最新ニュース

pulisher
May 30, 2025

Northern Trust Corp Has $913,000 Stock Position in Cidara Therapeutics, Inc. (NASDAQ:CDTX) - Defense World

May 30, 2025
pulisher
May 29, 2025

Cidara Therapeutics Stock (CDTX): A Notable Contender in Antivirals - Value The Markets

May 29, 2025
pulisher
May 28, 2025

Cidara Therapeutics (NASDAQ:CDTX) Given “Market Outperform” Rating at JMP Securities - Defense World

May 28, 2025
pulisher
May 27, 2025

JMP Securities Reiterates Market Outperform Rating for Cidara Therapeutics (CDTX) | CDTX Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Cidara stock target holds at $47 by JMP on trial confidence - Investing.com Canada

May 27, 2025
pulisher
May 27, 2025

Cidara Therapeutics, Inc. (NASDAQ:CDTX) Receives Average Rating of “Buy” from Analysts - Defense World

May 27, 2025
pulisher
May 27, 2025

(CDTX) On The My Stocks Page - news.stocktradersdaily.com

May 27, 2025
pulisher
May 25, 2025

Cidara Therapeutics: All Stars Aligning In Favor Of CD388 (NASDAQ:CDTX) - Seeking Alpha

May 25, 2025
pulisher
May 25, 2025

Royal Bank of Canada Increases Cidara Therapeutics (NASDAQ:CDTX) Price Target to $35.00 - Defense World

May 25, 2025
pulisher
May 25, 2025

Cidara Therapeutics’ (CDTX) Outperform Rating Reiterated at Royal Bank of Canada - Defense World

May 25, 2025
pulisher
May 25, 2025

Cidara Therapeutics (NASDAQ:CDTX) Earns Buy Rating from Needham & Company LLC - Defense World

May 25, 2025
pulisher
May 23, 2025

Cidara Therapeutics (CDTX) Receives Price Target Upgrade from RB - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Cidara Therapeutics (CDTX) Receives Price Target Upgrade from RBC Capital | CDTX Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

RBC Capital Ups Price Target for Cidara Therapeutics (CDTX) Amid Optimism | CDTX Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Cidara Therapeutics (CDTX): Analyst Reiterates Buy Rating | CDTX Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

RBC Raises Price Target on Cidara Therapeutics to $35 From $31, Keeps Outperform, Speculative Risk - marketscreener.com

May 23, 2025
pulisher
May 22, 2025

Transcript : Cidara Therapeutics, Inc.Special Call - marketscreener.com

May 22, 2025
pulisher
May 20, 2025

Seasonal Influenza Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Cidara, Moderna, SAB Therapeutics, Sinovac Biotech, Novartis - Barchart.com

May 20, 2025
pulisher
May 18, 2025

Cidara Therapeutics (NASDAQ:CDTX) Stock Price Expected to Rise, Guggenheim Analyst Says - Defense World

May 18, 2025
pulisher
May 16, 2025

CDTX Stock Price and Chart — NASDAQ:CDTX - TradingView

May 16, 2025
pulisher
May 16, 2025

When (CDTX) Moves Investors should Listen - news.stocktradersdaily.com

May 16, 2025
pulisher
May 16, 2025

Cidara Therapeutics (CDTX) Target Price Raised by Guggenheim | CDTX Stock News - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Cidara Therapeutics (CDTX) Target Price Raised to $50 by Guggenh - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Cidara Therapeutics (CDTX) Target Price Raised to $50 by Guggenheim | CDTX Stock News - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Cidara Therapeutics price target raised to $50 from $35 at Guggenheim - TipRanks

May 16, 2025
pulisher
May 15, 2025

Cidara Therapeutics to Host Virtual R&D Day to Discuss - GlobeNewswire

May 15, 2025
pulisher
May 15, 2025

Revolutionary Once-Per-Year Universal Flu Prevention: Cidara Unveils Phase 2b Trial Updates at R&D Day - Stock Titan

May 15, 2025
pulisher
May 13, 2025

Cidara Therapeutics to Participate in Two Upcoming Investor Conferences - GlobeNewswire

May 13, 2025
pulisher
May 12, 2025

Cidara Therapeutics’ CD388 Progress and Challenges Highlighted in Earnings Call - MSN

May 12, 2025
pulisher
May 12, 2025

Cidara Therapeutics (NASDAQ:CDTX) Price Target Raised to $35.00 - Defense World

May 12, 2025
pulisher
May 11, 2025

Cidara Therapeutics (NASDAQ:CDTX) Stock Price Expected to Rise, JMP Securities Analyst Says - Defense World

May 11, 2025
pulisher
May 11, 2025

Cidara Therapeutics, Inc. (NASDAQ:CDTX) Q1 2025 Earnings Call Transcript - Insider Monkey

May 11, 2025
pulisher
May 10, 2025

Guggenheim Raises Price Target for Cidara Therapeutics (CDTX) to $35.00 | CDTX Stock News - GuruFocus

May 10, 2025
pulisher
May 10, 2025

Analysts Offer Insights on Healthcare Companies: Aveanna Healthcare Holdings (AVAH), Caribou Biosciences (CRBU) and Cidara Therapeutics (CDTX) - The Globe and Mail

May 10, 2025
pulisher
May 10, 2025

StockNews.com Upgrades Cidara Therapeutics (NASDAQ:CDTX) to Sell - Defense World

May 10, 2025
pulisher
May 10, 2025

Cidara Therapeutics (CDTX) Target Price Raised by JMP Securities - GuruFocus

May 10, 2025
pulisher
May 09, 2025

Cidara Therapeutics (CDTX) Target Price Raised by JMP Securities | CDTX Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

RBC Cuts Price Target on Cidara Therapeutics to $31 From $34, Keeps Outperform, Speculative Risk - marketscreener.com

May 09, 2025
pulisher
May 09, 2025

Cidara Therapeutics (CDTX) Target Price Raised to $35 by Guggenheim | CDTX Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Cidara Therapeutics (CDTX) Sees Price Target Increase by Citizens JMP | CDTX Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Cidara Therapeutics: Q1 Earnings Snapshot - New Haven Register

May 09, 2025
pulisher
May 09, 2025

Cidara Therapeutics Inc (CDTX) Q1 2025 Earnings Call Highlights: Promising Advances in ... - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Cidara Therapeutics Inc (CDTX) Q1 2025 Earnings Call Highlights: Promising Advances in Influenza Prevention Amid Financial Challenges - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Cidara Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 09, 2025
pulisher
May 08, 2025

CDTX Targets Key Data Release for Influenza Treatment by Mid-202 - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Cidara Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 08, 2025
pulisher
May 08, 2025

CDTX Targets Key Data Release for Influenza Treatment by Mid-2025 | CDTX Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Cidara Therapeutics reports Q1 EPS ($1.66) vs. ($2.28) last year - TipRanks

May 08, 2025

Cidara Therapeutics Inc (CDTX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
大文字化:     |  ボリューム (24 時間):